(Q36170427)

12 August 2017

Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents (English)

1 reference

12 August 2017

Gram-negative bacteria

0 references

author name string

T Mazzulli

1

1 reference

12 August 2017

M Skulnick

2

1 reference

12 August 2017

G Small

3

1 reference

12 August 2017

W Marshall

4

1 reference

12 August 2017

D J Hoban

5

1 reference

12 August 2017

G G Zhanel

6

1 reference

12 August 2017

S Finn

7

1 reference

12 August 2017

D E Low

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Canadian Journal of Infectious Diseases & Medical Microbiology

12 August 2017

1 reference

12 August 2017

12

1 reference

12 August 2017

5

1 reference

12 August 2017

289-292

1 reference

Creative Commons Attribution 4.0 International

12 August 2017

start time

1 January 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

The mechanism of action of mecillinam

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Diagnosis and treatment of uncomplicated urinary tract infection

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Survey on antibiotic usage in the treatment of urinary tract infections.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Pivmecillinam in Treatment of Staphylococcus saprophyticus Urinary Tract Infections

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094837

Pivmecillinam treatment in acute cystitis. Three versus seven days study

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18159352

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2001/601743

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

18159352

1 reference